These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 26512778)
41. Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma. Mohammadizadeh F; Ghasemibasir H; Rajabi P; Naimi A; Eftekhari A; Mesbah A Cancer Biomark; 2009; 5(1):1-8. PubMed ID: 19242056 [TBL] [Abstract][Full Text] [Related]
42. The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. Pathmanathan N; Balleine RL; Jayasinghe UW; Bilinski KL; Provan PJ; Byth K; Bilous AM; Salisbury EL; Boyages J J Clin Pathol; 2014 Mar; 67(3):222-8. PubMed ID: 24403187 [TBL] [Abstract][Full Text] [Related]
43. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628 [TBL] [Abstract][Full Text] [Related]
44. Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer. Qin R; Smyrk TC; Reed NR; Schmidt RL; Schnelldorfer T; Chari ST; Petersen GM; Tang AH Br J Cancer; 2015 Feb; 112(3):514-22. PubMed ID: 25584484 [TBL] [Abstract][Full Text] [Related]
45. Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis. Huang M; Chen Q; Xiao J; Yao T; Bian L; Liu C; Lin Z Int J Gynecol Cancer; 2014 Jul; 24(6):1054-64. PubMed ID: 24978711 [TBL] [Abstract][Full Text] [Related]
46. Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma. Ni W; Yang Z; Qi W; Cui C; Cui Y; Xuan Y Hum Pathol; 2017 Nov; 69():38-45. PubMed ID: 28965964 [TBL] [Abstract][Full Text] [Related]
47. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer. Vleugel MM; Shvarts D; van der Wall E; van Diest PJ Hum Pathol; 2006 Aug; 37(8):1085-92. PubMed ID: 16867872 [TBL] [Abstract][Full Text] [Related]
48. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Schindl M; Schoppmann SF; Samonigg H; Hausmaninger H; Kwasny W; Gnant M; Jakesz R; Kubista E; Birner P; Oberhuber G; Clin Cancer Res; 2002 Jun; 8(6):1831-7. PubMed ID: 12060624 [TBL] [Abstract][Full Text] [Related]
49. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer. Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243 [TBL] [Abstract][Full Text] [Related]
50. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index. Serrero G; Hawkins DM; Bejarano PA; Ioffe O; Tkaczuk KR; Elliott RE; Head JF; Phillips J; Godwin AK; Weaver J; Hicks D; Yue B Diagn Pathol; 2016 Aug; 11(1):71. PubMed ID: 27501955 [TBL] [Abstract][Full Text] [Related]
51. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer. Yamashita H; Nishio M; Toyama T; Sugiura H; Zhang Z; Kobayashi S; Iwase H Breast Cancer Res; 2004; 6(1):R24-30. PubMed ID: 14680497 [TBL] [Abstract][Full Text] [Related]
52. Clinicopathologic characteristics and prognosis of glycogen-rich clear cell carcinoma of the breast. Ma X; Han Y; Fan Y; Cao X; Wang X Breast J; 2014; 20(2):166-73. PubMed ID: 24400866 [TBL] [Abstract][Full Text] [Related]
53. Ki67 Heterogeneity in Estrogen Receptor-Positive Breast Cancers: Which Tumor Type Has the Most Heterogeneity? Himuro T; Horimoto Y; Arakawa A; Tanabe M; Saito M Int J Surg Pathol; 2016 Apr; 24(2):103-7. PubMed ID: 26353854 [TBL] [Abstract][Full Text] [Related]
54. Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer. Dong M; Wan XB; Yuan ZY; Wei L; Fan XJ; Wang TT; Lv YC; Li X; Chen ZH; Chen J; Lin Q; Wen JY; Ma XK; Liu Q; Wu XY Med Oncol; 2013 Mar; 30(1):355. PubMed ID: 23408367 [TBL] [Abstract][Full Text] [Related]
55. Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. Dieci MV; Barbieri E; Bettelli S; Piacentini F; Omarini C; Ficarra G; Balduzzi S; Dominici M; Conte P; Guarneri V J Clin Pathol; 2012 Jun; 65(6):503-6. PubMed ID: 22389512 [TBL] [Abstract][Full Text] [Related]
56. Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer. Bjerre C; Knoop A; Bjerre K; Larsen MS; Henriksen KL; Lyng MB; Ditzel HJ; Rasmussen BB; Brünner N; Ejlertsen B; Laenkholm AV Acta Oncol; 2013 Jan; 52(1):82-90. PubMed ID: 23205744 [TBL] [Abstract][Full Text] [Related]
57. Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer. Ochnik AM; Baxter RC BMC Cancer; 2017 Dec; 17(1):820. PubMed ID: 29207959 [TBL] [Abstract][Full Text] [Related]
58. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. Tsutsumi Y Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930 [TBL] [Abstract][Full Text] [Related]
59. Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response. Kronblad A; Jirström K; Rydén L; Nordenskjöld B; Landberg G Int J Cancer; 2006 May; 118(10):2609-16. PubMed ID: 16381002 [TBL] [Abstract][Full Text] [Related]
60. GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroups. Ni YB; Tsang JY; Chan SK; Tse GM Histopathology; 2015 Jul; 67(1):96-105. PubMed ID: 25425335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]